Risk Taking in Asymmetric Tournaments
- 作者Matthias Kräkel; Dirk Sliwka
- 卷第5卷
- 期第1期
- 印刷ISSN1465-6485
- 电子ISSN1468-0475
- 文件大小116.51KB
- 发表时间2004
- DOI10.1111/j.1465-6485.2004.00096.x
- 页码103-116
Dramatic response to radiotherapy combined with vemurafenib. Is vemurafenib a radiosensitizer?Barouyr Baroudjian,Lise Boussemart,Emilie Routier… · European Journal of Dermatology · 2014
Synergistic Combination of Novel Tubulin Inhibitor ABI-274 and Vemurafenib Overcomes Vemurafenib Acquired Resistance in BRAFV600E MelanomaWang, J.; Chen, J.; Miller, D. D.; Li, W. · Molecular Cancer Therapeutics · 2014
Vemurafenib and cobimetinib overcome resistance to vemurafenib in <i>BRAF</i> -mutant gangliogliomaTouat, Mehdi; Gratieux, Julie; Condette Auliac, Stephanie; Sejean, Karine; Aldea, Sorin; Savatovsky, Julien; Perkins, Géraldine; Blons, Hélène; Ligon, Keith L.; Idbaih, Ahmed; Hollebecque, Antoine; Gimenez-Roqueplo, Anne-Paule; Laurent-Puig, Pierre; Sanson, Marc; Villa, Chiara; Di Stefano, Anna Luisa · Neurology · 2018
Two cases of successful treatment for severe skin rash induced by vemurafenib following nivolumab therapy without cessation of vemurafenibTsuboi, Satoshi; Yoshino, Koji; Yamaguchi, Kei; Imafuku, Keisuke; Ohara, Kuniaki · The Journal of Dermatology · 2016
Cobimetinib‑/Vemurafenib-assoziierte bilaterale seröse Retinopathie: ein Fallbericht; Cobimetinib/vemurafenib-associated bilateral serous retinopathy: a case report;Kastl, Gregor · Der Ophthalmologe · 2018
Effect of early adverse events on response and survival outcomes of advanced melanoma patients treated with vemurafenib or vemurafenib plus cobimetinib: A pooled analysis of clinical trial dataHopkins, Ashley M; Van Dyk, Madele; Rowland, Andrew; Sorich, Michael J · Pigment Cell & Melanoma Research · 2019
Association of PD-L1 expression with treatment outcomes in patients with <i>BRAF</i> mutation-positive melanoma treated with vemurafenib or cobimetinib combined with vemurafenibWongchenko, Matthew J.; Ribas, Antoni; Dréno, Brigitte; Ascierto, Paolo A.; McArthur, Grant A.; Gallo, Jorge D.; Rooney, Isabelle A.; Hsu, Jessie; Koeppen, Hartmut; Yan, Yibing; Larkin, James · Pigment Cell & Melanoma Research · 2017
Aflibercept, ipilimumab, and vemurafenibAu, Angelica Y. · 2012
Biperiden/trihexyphenidylReactions Weekly · 1995
NitrendipineReactions Weekly · 2003
ScopolamineReactions Weekly · 2007
ScopolamineReactions Weekly · 2012
ScopolamineReactions Weekly · 2009
Centella asiaticaReactions Weekly · 2011
Daunorubicin/mitoxantroneReactions Weekly · 2007
AnthracyclinesReactions Weekly · 1991